SB1844 prohibits prior authorization mandates and utilization management controls for FDA-approved mental health drugs in Illinois Medicaid.
SB1844 amends the Illinois Public Aid Code to prohibit prior authorization mandates and utilization management controls for FDA-approved prescription drugs treating mental illness under the state's Medicaid program. It allows certain safety edits, generic drug substitution, and controls necessary to comply with federal mandates. The Department of Healthcare and Family Services and managed care organizations must report quarterly on compliance with these prohibitions, starting July 1, 2025.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.